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A B S T R A C T
Introduction: Whether to treat metatarsal fractures conservatively or surgically is controversial. We test a
hypothesis that metatarsal fractures treated conservatively with non-invasive low-intensity pulsed
ultrasound (LIPUS) obtain heal rates comparable to current surgical techniques.
Patients and methods: This is a retrospective observational cohort study, using patient outcomes from a
prospectively-collected LIPUS registry required by the U.S. Food & Drug Administration. Registry data
were collected over a 5-year period and were reviewed and validated by a registered nurse. Data required
for analysis were days-to-treatment (DTT) with LIPUS and a dichotomous outcome of healed versus
failed, as assessed by clinical and radiographic criteria. Registry patients (DTT < 365 days) were
propensity-matched to metatarsal fracture patients from a health claims database that includes medical
and drug expenses for 90.1 million patients. The propensity match was based on patient demographic
data (age, gender, body weight, fracture severity, and smoking status).
Results: A total of 594 metatarsal fractures were treated with LIPUS, including 161 Jones fractures.
Compared to patients in the claims database, LIPUS-treated patients were more likely to: be overweight
or obese; be male; have open fracture; and smoke (all, P < 0.0001), suggesting that these variables were
perceived as nonunion risk factors by prescribing physicians. After propensity-matching, none of these
differences between the registry and the health claims database remained signiﬁcant. The heal rate with
LIPUS treatment was 97.3%, comparable to the heal rate of 95.3% among claims patients in 2011 who did
not receive LIPUS (P = 0.0654). When fresh fractures (0–90 days) and delayed unions (91–365 days) were
analyzed separately, the LIPUS fresh fracture heal rate was superior to claims patients (P = 0.0381), and
the delayed union heal rate was comparable. After exclusion of registry patients who received surgery,
heal rate with LIPUS alone (97.4%) was signiﬁcantly better (P < 0.0097) than the heal rate for matched
patients in 2011 (94.2%).
Conclusions: LIPUS signiﬁcantly improved the heal rate of metatarsal fractures <1 year old without
surgery (P = 0.0097). Metatarsal fractures treated with LIPUS alone have a heal rate comparable to
fractures treated by surgical intervention.
ã 2016 Bioventus LLC. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Whether to treat metatarsal fractures conservatively or
surgically is controversial; surgical intervention may reduce the
incidence of nonunion, but the complication rate of surgery can be
high, especially for the Jones (proximal diaphyseal ﬁfth) metatarsal
fracture [1]. An optimal metatarsal fracture treatment wouldnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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complication rate.
We evaluate the heal rate of metatarsal fractures treated with
low-intensity pulsed ultrasound (LIPUS). High-frequency LIPUS
was patient self-administered to the fracture site with a home-use
device that stimulates the bone-healing process when used once a
day for 20 min. LIPUS-treated fractures are compared to fractures
treated with a mix of other methods in 2011, using a propensity-
matching approach [2]. Propensity can be deﬁned as the
probability that an individual patient will be treated with a
particular intervention, given what is known about that patient [2].
A propensity score is thus a way of combining all relevant
information about a patient into a single metric, so that a treated
patient can be matched to a non-treated patient [2]. In this case,
the treatment of interest is LIPUS, the source of data on LIPUS was a
device registry required by the U.S. Food & Drug Administration
(FDA), and registry patients were matched to similar patients from
a 2011 health claims database (Truven Health Analytics, Durham,
NC). We hypothesize that LIPUS yields heal rates comparable to
current surgical techniques.
Patients and methods
This study was designed as a retrospective, observational
cohort study of a convenience sample of consecutive consenting
patients with metatarsal fracture, all of whom enrolled prospec-
tively in a LIPUS registry. Metatarsal fractures in the registry wereFig. 1. Propensity score-matching of registry data to Truven data, for days 0–365, excludin
of logit scores by source prior to the match, and Panel B (top right) shows that the distrib
Panel C (bottom left) shows the distribution of logit scores, and Panel D (bottom rightidentiﬁed as such by X-ray and clinical ﬁndings. The protocol for
the registry is publicly available [3]; inclusion criteria were that
patients be males or non-pregnant females 18 years or older at
enrollment and that patients sign an informed consent. Patients
were instructed to use the device for 20 min daily until healed.
Analysis of these patients was formally exempted from ethical
approval by the Institutional Review Board of the Duke University
School of Medicine, because data were derived from a post-market
registry designed to satisfy FDA reporting requirements [3].
Registry data for the period from 14 Oct 1994 until 15 Oct 1998
were validated by a registered nurse who manually compared
every patient’s paper record to the digital record [3]. Each patient
was required to have four data points [3]:
 Date of fracture: Calendar date when the fracture occurred
 Date LIPUS treatment started: Calendar date when LIPUS
treatment began
 Date LIPUS treatment ended: Calendar date when LIPUS
treatment ended
 Outcome: A dichotomous variable of healed/failed at treatment
end, as determined by the prescribing physician. For a fracture to
be healed, the registry protocol speciﬁed that a fracture had to
meet both clinical and radiological criteria:
 No motion or tenderness with palpation
 At least three of four cortices bridged on X-ray viewsg surgery patients in the registry database. Panel A (top left) shows the distribution
ution of logit scores overlaps poorly prior to the match. After the propensity match,
) shows that these scores overlap almost completely.
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interest:
 Days-to-treatment (DTT): Number of days until LIPUS treatment
was initiated, calculated as “Date LIPUS treatment started” minus
“Date of fracture”.
 Days-on-treatment (DOT): Time the patient used LIPUS before
attaining an outcome.
Registry patients with DTT and a dichotomous outcome of
healed versus failed were propensity-matched to patients in a
health claims database of medical and drug expenses obtained
from Truven Health Analytics (Durham, NC). The Truven database
includes 90.1 million patients, with information compiled from
patient-level health claims for medical and drug expenses,
together with laboratory test results, hospital discharge, and
death data. These data were submitted by hospitals, managed care
organizations, Medicare and Medicaid programs, and roughly 300
large corporations, in exchange for benchmark reports. We
obtained a download of data from Truven in February 2015.
We compared registry patients with metatarsal fracture to
those Truven patients with both a coded metatarsal fracture in
2011 and continuous enrollment for 12 months after fracture.
Registry patients were propensity-matched to Truven patients
using demographic data (age, gender, body-mass index (BMI),
fracture severity, and smoking status). The rationale for using
demographic data only was that patient descriptors would likely
not change much, even if surgical techniques and other treatments
changed substantially. The propensity match was done with the
logit method, using log-transformed data (Fig. 1). Analysis was
conducted ﬁrst for registry patients with DTT < 365 days, including
both fresh fracture and delayed/nonunion fractures. Then, analysis
was done separately for patients with fresh fracture (DTT < 90
days) and delayed/nonunion fracture (90 days < DTT < 365 days).
We make no effort to discern between delayed union and
nonunion because the boundary between the two conditions is
controversial [4].
A t-statistic was used to test for signiﬁcance when comparing
continuous variables (e.g., mean age) and a Cochran-Mantel-
Haenszel test was used for categorical variables (e.g., gender, BMI
category, open/closed fracture, and smoking status). Since this is an
exploratory study, no adjustment for multiplicity is needed and theTable 1
Fracture location and fracture type for all patients in the Registry (0–365 days). Heal
rate is calculated as the number of patients healed divided by the number of
patients treated.
Category Healed Treated Heal rate
Fracture location Missing/Unknown 227 239 95.0
Neck 8 8 100.0
Proximal 62 64 96.9
Middle 63 64 98.4
Distal 31 31 100.0
Jones fracture 159 161 98.8
Mid-foot 5 5 100.0
Distal shaft 7 7 100.0
Proximal shaft 11 11 100.0
Fracture type Simple closed fractures 371 377 98.4
All other fractures 206 217 94.9
Open 6 6 100.0
Open Grade II 1 1 100.0
Osteotomy 57 65 87.7
Stress 47 48 97.9
Open comminuted 2 2 100.0
Closed comminuted 18 19 94.7
Closed spiral 8 8 100.0
Closed oblique 29 29 100.0
Closed transverse 38 39 97.4signiﬁcance level is 0.05. All data were analyzed using SAS
software, v9.3 (Cary, NC).
Results
A total of 594 metatarsal fracture patients were available for
propensity-score matching in the Registry with fresh fracture or
delayed/nonunion (DTT  365 days). In this cohort, 368 patients
had fresh fracture (DTT  90 days) and 226 patients had delayed/
nonunion fracture (90 days < DTT  365 days). Fracture location
was unknown for 40.2% (239/594) of registry patients (Table 1), but
27.1% of these patients (161/594) had Jones fracture. Roughly 63.5%
(377/594) of metatarsal fractures in the registry were simple
closed fractures (Table 1).
Prior to the propensity match, metatarsal fracture patients in
the registry differed from Truven patients in important ways
(Table 2; Fig. 1). Registry patients were more likely to be
overweight, obese, or morbidly obese; more likely to be male;
more likely to have open fracture; and more likely to smoke (all,
P < 0.0001). These differences suggest that BMI, gender, fracture
severity, and smoking habit were all regarded as risk factors for
nonunion when patients were enrolled in the registry. Despite
these demographic differences, LIPUS-treated patients had a heal
rate comparable to patients with metatarsal fracture in the 2011
Truven database.
Following the propensity match, all signiﬁcant differences
between registry and Truven patients were non-signiﬁcant
(Table 2; Fig. 1). Heal rate of LIPUS-treated patients was
comparable (P = 0.0654) to the heal rate of patients treated in 2011.
Similar results were obtained when comparing fresh metatarsal
fractures in the registry to propensity-matched fractures in Truven
(Table 3). Prior to the match, registry patients were more likely to
be heavy; more likely to be male; more likely to have an open
fracture; and more likely to smoke (all, P < 0.0001). However, the
heal rate in registry patients with these risk factors was
comparable to the heal rate of Truven patients. After propensi-
ty-matching for potential risk factors, all demographic differences
between the registry and Truven disappeared, but LIPUS-treated
patients had a signiﬁcantly and substantially better heal rate
(P = 0.0381) at 98.1%. These ﬁndings conﬁrm that the demographic
variables seen as risk factors for nonunion in the registry did
reduce the heal rate among patients in 2011 (Table 3). Similar
results were seen in metatarsal fractures classiﬁed as delayed/
nonunion fractures (90 days < DTT < 365 days), except the heal
rate of delayed/nonunion fractures with LIPUS was comparable to
the 2011 database (Table 4). This result may reﬂect the fact that the
sample size at N = 226 (Table 4) was rather small.
When LIPUS-treated patients who received concurrent surgery
are excluded from analysis (Table 5), the heal rate with LIPUS is
97.4%, signiﬁcantly better than the heal rate of matched patients in
the Truven database (P = 0.0097). Patients in the Truven database
received standard treatment in 2011, which could have included
operative intervention. This suggests that the heal rate with LIPUS
may be superior to the heal rate with surgery (Table 5).
A literature review (Table 6) of clinical studies of metatarsal
fracture [5–32] shows that operatively-treated metatarsal frac-
tures have an overall heal rate of 96.8% (724 healed/748 treated).
This heal rate is comparable to the heal rate in the Truven database
(Table 2), as expected. The operative heal rate (96.8%) is
signiﬁcantly better (x2 test; P = 0.0002) than the heal rate of
92.3% (603 healed/653 treated) for conservatively-treated meta-
tarsal fracture (Table 6). Overall, the metatarsal heal rate with
LIPUS (98.5% or 331 healed/336 treated; Table 5) is comparable to
the operative heal rate (x2 test; P = 0.8503) and signiﬁcantly better
than the conservative heal rate (x2 test; P < 0.0001).
Table 2
Comparison of all metatarsal fracture patients (0–365 days) treated with LIPUS (Registry) versus non-LIPUS treatment (Truven). P values shown are from t-tests for continuous
variables (age) or Cochran-Mantel-Haenszel for dichotomous variables (gender, severity, smoking, outcome). The relative risk of nonunion in the Truven database compared
to the registry is 1.75 (0.96; 3.20).
All fractures Prior to propensity-match Following propensity-match
Variable Category Registry Truven P-value Registry Truven P-value
Number of patients (no.) 594 83,113 – 594 594 –
Age, years (mean  SD) 39.1 (15.7) 40.4 (21.3) 0.0524 39.1 (15.7) 39.3 (16.0) 0.8937
BMI (no., %) Normal/Unknown 315 (53.0%) 77,409 (93.1%) <0.0001 315 (53.0%) 345 (58.1%) 0.2955
Overweight 155 (26.1%) 475 (0.6%) 155 (26.1%) 72 (12.1%)
Obese 101 (17.0%) 3197 (3.8%) 101 (17.0%) 143 (24.1%)
Morbidly obese 23 (3.9%) 2032 (2.4%) 23 (3.9%) 34 (5.7%)
Gender (no., %) Male 284 (47.8%) 27,992 (33.7%) <0.0001 284 (47.8%) 269 (45.3%) 0.0501
Female 310 (52.2%) 55,121 (66.3%) 310 (52.2%) 325 (54.7%)
Severity (no., %) Open 74 (12.5%) 413 (0.5%) <0.0001 74 (12.5%) 71 (12.0%) 0.7904
Closed 520 (87.5%) 82,701 (99.5%) 520 (87.5%) 523 (88.0%)
Smoking (no., %) Never 407 (68.5%) 78,760 (94.8%) <0.0001 407 (68.5%) 410 (69.0%) 0.8511
Ever 187 (31.5%) 4353 (5.2%) 187 (31.5%) 184 (31.0%)
Outcome (no., %) Failed 16 (2.7%) 3216 (3.9%) 0.1383 16 (2.7%) 28 (4.7%) 0.0654
Healed 578 (97.3%) 79,897 (96.1%) 578 (97.3%) 566 (95.3%)
Table 3
Comparison of fresh metatarsal fracture patients (0–90 days) treated with LIPUS (Registry) versus non-LIPUS treatment (Truven). P values shown are from t-tests for
continuous variables (age) or Cochran-Mantel-Haenszel for dichotomous variables (gender, severity, smoking, outcome). The relative risk of nonunion in the Truven database
compared to the registry is 2.43 (1.02; 5.79).
Fresh fractures Prior to propensity-match Following propensity-match
Variable Category Registry Truven P-value Registry Truven P-value
Number of patients (no.) 368 83,113 – 368 368 –
Age, years (mean  SD) 36.9 (15.6) 40.4 (21.3) <0.0001 36.9 (15.6) 38.7 (17.9) 0.1327
BMI (no., %) Normal/Unknown 202 (54.9%) 77,409 (93.1%) <0.0001 202 (54.9%) 209 (56.8%) 0.0303
Overweight 102 (27.7%) 475 (0.6%) 102 (27.7%) 52 (14.1%)
Obese 54 (14.7%) 3197 (3.8%) 54 (14.7%) 78 (21.2%)
Morbidly obese 10 (2.7%) 2032 (2.4%) 10 (2.7%) 29 (7.9%)
Gender (no., %) Male 202 (54.9%) 27,992 (33.7%) <0.0001 202 (54.9%) 186 (50.5%) 0.2378
Female 166 (45.1%) 55,121 (66.3%) 166 (45.1%) 182 (49.5%)
Severity (no., %) Open 31 (8.4%) 412 (0.5%) <0.0001 31 (8.4%) 27 (7.3%) 0.5845
Closed 337 (91.6%) 82,701 (99.5%) 337 (91.6%) 341 (92.7%)
Smoking (no., %) Never 265 (72.0%) 78,760 (94.8%) <0.0001 265 (72.0%) 267 (72.6%) 0.8693
Ever 103 (28.0%) 4353 (5.2%) 103 (28.0%) 101 (27.4%)
Outcome (no., %) Failed 7 (1.9%) 3216 (3.9%) 0.0506 7 (1.9%) 17 (4.6%) 0.0381
Healed 361 (98.1%) 79,897 (96.1%) 361 (98.1%) 351 (95.4%)
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Low-intensity pulsed ultrasound (LIPUS) is well-documented to
enhance heal rate of fractures under a range of conditions [33].
However, closed non-displaced metatarsal fractures are expectedTable 4
Comparison of delayed/nonunion metatarsal fracture patients (91–365 days) treated wit
tests for continuous variables (age) or Cochran-Mantel-Haenszel for dichotomous variab
database compared to the registry is 1.56 (0.69; 3.52).
Delayed unions Prior to propensity-match 
Variable Category Registry Truven
Number of patients (no.) 226 83,113
Age, years (mean  SD) 42.8 (15.2) 40.4 (
BMI (no., %) Normal/Unknown 113 (50.0%) 77,409
Overweight 53 (23.5%) 475 (0
Obese 47 (20.8%) 3197 (
Morbidly obese 13 (5.8%) 2032 (
Gender (no., %) Male 82 (36.3%) 27,992
Female 144 (63.7%) 55,121
Severity (no., %) Open 43 (19.0%) 412 (0
Closed 183 (81.0%) 82,701
Smoking (no., %) Never 142 (62.8%) 78,760
Ever 84 (37.2%) 4353 (
Outcome (no., %) Failed 9 (4.0%) 3216 (
Healed 217 (96.0%) 79,897to heal well in any case. Consistent with this, we report that 98.4%
of LIPUS-treated simple closed fractures healed (Table 1), as did
94.9% of all other metatarsal fractures (Table 1). The heal rate for
metatarsal fractures treated with LIPUS is therefore comparable to
the heal rate of metatarsal fractures treated with surgical or otherh LIPUS (Registry) versus non-LIPUS treatment (Truven). P values shown are from t-
les (gender, severity, smoking, outcome). The relative risk of nonunion in the Truven
Following propensity-match
 P-value Registry Truven P-value
 – 226 226 –
21.3) 0.0166 42.8 (15.2) 43.3 (15.5) 0.7385
 (93.1%) <0.0001 113 (50.0%) 116 (51.3%) 0.4016
.6%) 53 (23.5%) 39 (17.3%)
3.8%) 47 (20.8%) 48 (21.2%)
2.4%) 13 (5.8%) 23 (10.2%)
 (33.7%) 0.4092 82 (36.3%) 90 (39.8%) 0.4388
 (66.3%) 144 (63.7%) 136 (60.2%)
.5%) <0.0001 43 (19.0%) 35 (15.5%) 0.3199
 (99.5%) 183 (81.0%) 191 (84.5%)
 (94.8%) <0.0001 142 (62.8%) 136 (60.2%) 0.5624
5.2%) 84 (37.2%) 90 (39.8%)
3.9%) 0.93 9 (4.0%) 14 (6.2%) 0.2851
 (96.1%) 217 (96.0%) 212 (93.8%)
Table 5
Comparison of metatarsal fracture patients (0–365 days) treated with LIPUS alone (Registry), without concurrent surgery, versus non-LIPUS treatment (Truven). P values
shown are from t-tests for continuous variables (age) or Cochran-Mantel-Haenszel for dichotomous variables (gender, severity, smoking, outcome). The relative risk of
nonunion in the Truven database compared to the registry is 2.21 (1.19; 4.11).
No surgery patients Prior to propensity-match Following propensity-match
Variable Category Registry Truven P-value Registry Truven P-value
Number of patients (no.) 535 83,113 – 535 535 –
Age, years (mean  SD) 39.0 (15.6) 40.4 (21.3) 0.0424 39.0 (15.6) 39.3 (15.8) 0.7617
BMI (no., %) Normal/Unknown 282 (52.7%) 77,409 (93.1%) <0.0001 282 (52.7%) 293 (54.8%) 0.0099
Overweight 144 (26.9%) 475 (0.6%) 144 (26.9%) 66 (12.3%)
Obese 89 (16.6%) 3197 (3.8%) 89 (16.6%) 130 (24.3%)
Morbidly obese 20 (3.7%) 2032 (2.4%) 20 (3.7%) 46 (8.6%)
Gender (no., %) Male 259 (48.4%) 27,992 (33.7%) <0.0001 259 (48.4%) 238 (44.5%) 0.1982
Female 276 (51.6%) 55,121 (66.3%) 276 (51.6%) 297 (55.5%)
Severity (no., %) Open 60 (11.2%) 412 (0.5%) <0.0001 60 (11.2%) 47 (8.8%) 0.1855
Closed 475 (88.8%) 82,701 (99.5%) 475 (88.8%) 488 (91.2%)
Smoking (no., %) Never 366 (68.4%) 78,760 (94.8%) <0.0001 366 (68.4%) 366 (68.4%) >0.99
Ever 169 (31.6%) 4353 (5.2%) 169 (31.6%) 169 (31.6%)
Outcome (no., %) Failed 14 (2.6%) 3216 (3.9%) 0.1339 14 (2.6%) 31 (5.8%) 0.0097
Healed 521 (97.4%) 79,897 (96.1%) 521 (97.4%) 504 (94.2%)
Table 6
Literature heal rates for metatarsal fractures.
Pts treated Healed Failed Heal rate (%) Summary Year First author
Conservatively-treated Jones fractures
40 33 7 82.5 Jones fracture treated with bandage or cast 1994 Josefsson
60 60 0 100.0 Prospective Jones fracture treatment with cast or dressing 1997 Wiener
18 12 6 66.7 Casting for treatment of Jones fracture 2005 Mologne
23 23 0 100.0 Conservative treatment of avulsion and Jones fractures 2007 Van Aaken
Conservatively-treated non-Jones fractures
20 15 5 75.0 Fracture of proximal part of the ﬁfth metatarsal shaft 1975 Dameron
25 19 6 76.0 Acute fracture of ﬁfth metatarsal treated with a cast 1984 Torg
100 93 7 93.0 Fractures of the ﬁfth metatarsal: Analysis of a registry 1995 Clapper
35 33 2 94.3 Distal ﬁfth metatarsal shaft fracture in elite dancers 1996 O’Malley
50 47 3 94.0 RCT of acute metatarsal fracture treated with cast or bandage 2005 Zenios
37 35 2 94.6 Conservative treatment of tuberosity fractures 2008 Gray
24 20 4 83.3 Conservative treatment of ﬁfth metatarsal fracture 2008 Chuckpaiwong
142 137 5 96.5 Nonoperative management of ﬁfth metatarsal fracture 2013 Aynardi
79 76 3 96.2 Fifth metatarsal fractures managed conservatively 2014 Nagar
653 603 50 92.3 Overall heal rate with conservative treatment
Operatively-treated Jones fractures
22 22 0 100.0 Intramedullary screw ﬁxation of Jones fracture 2003 Portland
17 16 1 94.1 Jones fractures in NFL players treated with IM screw 2004 Low
19 18 1 94.7 Early screw ﬁxation for treatment of Jones fracture 2005 Mologne
23 23 0 100.0 Jones fracture ﬁxation with a cannulated screw 2005 Porter
21 21 0 100.0 Cannulated screw for repair of Jones fracture 2008 Raikin
20 20 0 100.0 Jones fractures ﬁxation with 4.5 and 5.5 mm cannulated screws 2009 Porter
53 50 3 94.3 Cannulated screw ﬁxation of Jones fracture 2011 DeVries
23 23 0 100.0 Operative treatment of proximal ﬁfth metatarsal fracture 2011 Mahajan
60 59 1 98.3 Headless compression screw for Jones fracture 2012 Nagao
55 51 4 92.7 Failed surgical management of Jones fracture 2015 Granata
25 25 0 100.0 Return to play in the NFL after operative Jones fracture 2015 Lareau
Operatively-treated non-Jones fractures
37 37 0 100.0 Operative treatment of ﬁfth metatarsal fracture 2008 Chuckpaiwong
124 124 0 100.0 Proximal ﬁfth fracture treated with XS-nail or tension wire 2010 Renner
35 34 1 97.1 Displaced ﬁfth metatarsal fractures using K-wires 2010 Koslowsky
20 19 1 95.0 Diaphyseal stress fracture in athletes treated with IM nails 2011 Pecina
26 25 1 96.2 Internal ﬁxation of ﬁfth metatarsal in athletes 2011 Murawski
168 157 11 93.5 Fifth metatarsal stress fracture treated with tension band 2013 Lee
748 724 24 96.8 Overall heal rate with surgical treatment
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LIPUS-treated patients had more risk factors for fracture nonunion,
including obesity, open fracture, and smoking (Table 2). When
propensity-matching was used to match registry patients to
Truven patients with similar risk factors, the heal rate of LIPUS-
treated patients was superior to that of metatarsal fracture
patients treated in 2011 (Table 2). Fresh metatarsal fractures
treated with LIPUS also healed better than patients in 2011
(Table 3), and delayed/nonunion metatarsal fractures treated with
LIPUS had a comparable healing rate (Table 4). Patients treatedwith LIPUS who did not receive surgery healed signiﬁcantly better
than patients with similar risk factors in 2011 (Table 5), some of
whom likely received surgery. This argues strongly that LIPUS is
effective, consistent with the surgical literature (Table 6).
LIPUS-treated patients at risk for nonunion healed at a rate
comparable to patients in 2011 even without a propensity-match
(Table 2). This suggests either that LIPUS was able to overcome the
risk factors or that these risk factors were not actually important in
determining nonunion. We believe that LIPUS was able to
overcome risk factors that were important in determining the
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was 96.1% overall; these patients represent a random selection of
all metatarsal fracture patients (Table 2). Yet Truven patients who
were propensity-matched to registry patients with risk factors
healed at a rate of only 95.3% (Table 2), which is signiﬁcantly less
than unselected Truven patients. This suggests that BMI, gender,
fracture severity, and smoking habit are all important risk factors
for nonunion of metatarsal fracture.
There has been controversy as to whether metatarsal fractures
should be treated conservatively or surgically. Some authors have
claimed that, “All undisplaced metatarsal fractures . . . can be
treated nonoperatively” [34], while other authors stated that
“surgical treatment by open reduction and internal ﬁxation . . . or
closed reduction with percutaneous K-wiring is recommended”
[35]. A recent systematic review speciﬁc to Jones fracture
concluded that intramedullary screw ﬁxation is more likely to
lead to successful union than is any non-operative treatment [36].
Yet even in discussing Jones fracture there is controversy; some
authors claim that “surgical intervention for the acute Jones
fracture should be reserved for the athletic individual” 1, although
it is not clear how to deﬁne an athletic individual. The pooled heal
rate for Jones fractures treated with a screw was 96% [36], whereas
we report a 98.8% heal rate for 161 Jones fractures treated with
LIPUS (Table 1). Pooled literature-reported results (Table 6)
strongly suggest that conservative treatment is not enough.
However, conservative treatment with adjunctive LIPUS results
in a heal rate superior to the metatarsal heal rate attained in 2011
(Table 5). Therefore, if a decision is made to treat a metatarsal
fracture conservatively, then LIPUS should be considered as
adjunctive therapy.
Several limitations of this study are worth noting. Most
importantly, patients were not entered into the registry randomly;
physicians were free to enter any patient whom they thought could
beneﬁt. Evidence is consistent with the idea that patients at risk of
nonunion were preferentially enrolled in the registry (Table 2), but
we cannot prove this. A second limitation is that patients in the
registry from 1994 to 1998 were compared to patients who may
have received surgery up to 17 years later. Surgical methods
evolved between 1998 and 2011 and the conceptualization as to
which metatarsal fracture patients require surgery may also have
evolved [37]. Many patients may now receive surgery who would
have been conservatively treated 20 years ago. If surgery truly is
effective in facilitating healing, one would expect healing to be
better in 2011, thereby creating a bias against patients in the
registry. That non-surgical patients treated with LIPUS healed
better than patients treated in 2011 (Table 5) argues strongly that
LIPUS is effective. A third limitation is that there may be pitfalls
inherent to the propensity-matching method itself. Propensity-
matching is meant to compensate for “confounding by indication”;
patients chosen to receive an intervention almost certainly differ
from similar patients not chosen to receive that intervention [2].
However, propensity-matching can only balance patient character-
istics that are considered in the matching effort; unknown risk
factors that differ between treated and untreated patients may not
be balanced [38].
Strengths of the present work are several-fold. Most impor-
tantly, the registry includes prospectively-assessed real-world
patients that are likely to reﬂect the reality of the clinic. Secondly,
the large sample size, especially of Jones fractures, means that this
work is less prone to the random variation that can impact small
studies, which may be vulnerable to reporting bias [39].
Conclusions
LIPUS treatment of metatarsal fractures yields heal rates that
are at least comparable to surgical treatment and are superior toconservative treatment. That healing can happen in a less invasive
way argues strongly that LIPUS should be considered for every
metatarsal fracture patient.
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